FDA approves Lundbeck's Sabril for seizures in over-10s
This article was originally published in Scrip
Executive Summary
The US FDA has approved Lundbeck's Sabril (vigabatrin) as an adjunctive treatment for children aged 10 years and older with refractory complex partial seizures (CPS).